Searched for
ORBIMED
360 ONE to finance AIMS founder's stake buybackThe asset management firm is expected to lend about ₹600 crore to facilitate the repurchase of shares from British International Investment...- Venture Catalysts exits hygiene startup Pee Safe with 9.6x return after OrbiMed-led $32 million roundOther investors, including We Founder Circle, Alkemi Growth Capital and Alpha Capital, have also exited the company, Venture Catalysts foun...
- Wellness brand Pee Safe closes a $32 million funding round with OrbiMedPee Safe has closed a $32 million round with OrbiMed, a global healthcare-focused private equity firm. The company plans to deploy the capi...
- Laxmi Dental raises Rs 314 crore from anchor investors ahead of IPOOrbiMed-backed Laxmi Dental raised over Rs 314 crore from anchor investors before its IPO for public subscription. The anchor round include...
- General Atlantic, other PE funds in talks for majority stake in AIMSGeneral Atlantic and KKR are among several private equity firms vying for a majority stake in Faridabad-based Asian Institute of Medical Sc...
- OrbiMed-backed Suraksha Diagnostic files IPO papersOrbiMed-backed Suraksha Diagnostic has filed the draft red herring prospectus (DRHP) with capital markets regulator SEBI to float an initia...
- Arcatron Mobility raise growth capital from OrbiMed, a global healthcare-focused investment firmArcatron Mobility has raised growth capital from OrbiMed, a global healthcare-focused investment firm. The funds will be used to increase R...
- Entero gets Sebi nod for IPOThe Company’s initial public offering comprises a fresh issue of up to Rs 1000 crore and an offer for sale of up to 8,557,597 equity shares.
- Innvolution secures growth capital from OrbiMed to advance R&D, expand product line and enter global marketsInnvolution has recently received substantial growth capital from OrbiMed, an investment firm dedicated to healthcare
- Troubled Mfine merges with Lifecell International, raises $80 millionMfine will remain the app and consumer brand for digital healthcare services like tele-consultations, care plans, diagnostic tests.
- Advent to buy majority stake in Bharat SerumsUS-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...
- Vivimed Labs gets additional $7.5 million funding from OrbiMed AsiaThe company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.
- OrbiMed to invest $40 million in Suraksha DiagnosticsSuraksha, promoted by Panorama Group, operates more than 30 centres including polyclinics and has expanded services to include cardiology ,...
- Online pharmacy marketplace Netmeds.com secures Rs 324 crore in fundingNetmeds.com has secured Rs 324 crore ($50 million) in funding from a clutch of investors led by healthcare-focused investment firm OrbiMed.
- OrbiMed leads $50 million funding round in online pharma marketplace Netmeds.comAdditionally in May earlier this year, ET had reported that MAPE Advisory Group was investing in the still yet-to-be launched Netmeds.com.
- Shasun Pharma to invest Rs 250 crore in expansion next fiscalThe company has received approval to raise Rs 50 crore through preferential allotment of shares to Caduceus Asia Mauritius
- Shasun Pharmaceuticals to sell 11.93 stake to US firm OrbiMed for Rs 50 croreShasun Pharmaceuticals said its board has approved to sell 11.93 per cent stake to US- based healthcare investment firm OrbiMed for Rs 50 c...
- Mauritius-based PE to pick up 12% in Shasun Pharmaceuticals for Rs 50 crore: Abhaya Kumar, MD, Shasun PharmaA Mauritius-based fund registered with the Government of India is investing Rs 50 crore into Shasun Pharmaceuticals.
- PE funds to buy stakes in Kerala Institute of Medical SciencesPrivate equity funds OrbiMed and Ascent Capital will pick up a minority stake in Kerala Institute of Medical Sciences for close to Rs 170 c...
- Piramal Life Sciences gain on stake sale buzzShares of Piramal Life Sciences extended gains to as much as 13 per cent after media reports that healthcare funds MPM Capital and OrbiMed ...
Load More
